Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or... – Recovery or purification
Patent
1996-07-22
1997-12-16
Elliott, George C.
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
Recovery or purification
4352351, 4242091, C12N 702, A61K 3900
Patent
active
056984332
ABSTRACT:
A method of producing an influenza virus and vaccines derived from the virus utilizes cultured vertebrate biomass aggregates comprising a plurality of cell types derived from a plurality of vertebrate tissues and is particularly suitable for use with chicken embryo cultures. The method both eliminates the necessity to use costly methods requiring whole chicken embryos and provides proteases suitable for the activation of a wide variety of viruses. After infecting the cells of the culture with an influenza virus, which is preferably modified to create a cleavage site in the hemagglutinin of the virus, a substance such as a protease is introduced that cleaves the hemagglutinin. The culture then is incubated under conditions that permit growth of the virus. The method provides also for the augmentation of virus activation in the culture by the continuous or batchwise removal of culture media, treatment of the media with substances such as proteases which increase cellular activation, attenuation of any undesired effects of the augmentation and return of the augmented media to the culture. The vaccines produced from the harvested virus therefore are free of egg proteins and are much more economical to produce. The methodology of the present invention allows the large scale continuous production of many viruses to a high titre.
REFERENCES:
patent: 4072565 (1978-02-01), Weiss et al.
patent: 4205131 (1980-05-01), Almedia
patent: 4500513 (1985-02-01), Brown et al.
patent: 4525349 (1985-06-01), Montagnon et al.
patent: 4664912 (1987-05-01), Wiktor et al.
patent: 4783411 (1988-11-01), Gabliks
patent: 4927762 (1990-05-01), Darfler
patent: 5147790 (1992-09-01), Wilson
patent: 5316938 (1994-05-01), Keen et al.
patent: 5391491 (1995-02-01), Mundt et al.
patent: 5393668 (1995-02-01), Cinatl et al.
Cinatl et al. Arch Virol 125: 327-330 (1992).
Cinatl et al. Intervirology 37:361-366 (1994).
Cinatl et al. Biology International, vol. 17: No. 9 (1993).
Nakamura et al. J. Gen. Virol. 56: 199-202 (1981).
Lau et al. Virology 212:225-231 (1995).
Vey et al. J. Virol. 188:1 408-411 (1992).
Merten et al. Cytotechnology 14: 47-59 (1994).
Merten et al. Biologicals 23: 185-189 (1995).
Swanson et al. Journal of Biological Standardization 16:311-320 (1988).
Levenbrook et al. Journal of Biological Standardization 12; 391-398 (1984).
Contreras et al. In Vitro Cellular & Developmental Biology 21(11):649-652 (1985).
Johnson et al. Develop. biol. Standard. 50: 27-35 (1982).
Katz et al. The Journal of Infectious Diseases 160(2): 191-198 (1989).
Kaverin et al. The Journal of Virology, 69(4): 2700-2703 (1995).
Govorkova et al. The Journal of Infectious Diseases 172: 250-253 (1995).
Bulletin of the World Health Organization 73(4): 431-435 (1995).
Vincent-Falquet et al. Develop. biol. Standard. 70: 153-156 (1989).
Enami et al. Proc. Natl. Acad. Sci. USA 87: 3802-3805 (1990).
Luytjes et al. Cell 59: 1107-1113 (1989).
Robertson et al. Journal of General Virology 72:2671-2677 (1991).
Scild et al. Nature 303: 706-709 (1983).
Tomas et al., Rev. Roum. Med. Virol., 1981, vol. 32(2): pp. 145-154.
Klenk et al. "The Molecular Biology of Influenza Virus Pathogenicity", pp. 247-281, Academic Press (1988).
Edsall et al. "Requirements For Inactivated Influenza Vaccine", WHO: Technical Report Series, 384:41-56 (1968).
Steineke-Grober et al. "Influenza virus hemagglutinin with multibasic cleavage site is activated by furin . . . ", The EMBO Journal, 11:2407-2414 (1992).
Lazarowitz et al. "Enhancement of the Infectivity of Influenza A and B Viruses by Proteolytic Cleavage . . . ", Virology, 68:440-454 (1975).
Hirst "The Agglutination Of Red Cells By Allantoic Fluid Of Chick Embryos Infected With Influenza Virus", Science, 94:22-23 (1941).
Barrett et al. "Viruses", Methods of Immunological Analysis, 2:115-132 (1993).
Scholtissek et al. "Multiplication of Influenza A Viruses with Cleavable and Non-cleavable Haemagglutinin . . . ", J. Gen. Virol., 69:2155-2165 (1988).
Barr "Mammalian Subtilisins: The Long-Sought Dibasic Processing Endoproteases", Cell, 66:1-3 (1991).
Burnet "Influenza Virus Infections Of The Chick Embryo By The Amniotic Route", Austr. Jnl. Experimental Biology and Medical Science, 18:353-360 (1940).
Ohuchi et al., Journal of Virology, 65(7): 3530-3537 (Jul. 1991).
Boehringer Mannheim Catalog, pp. 191-195 (1994).
Barrett Noel
Dorner Friedrich
Kistner Otfried
Mundt Wolfgang
Elliott George C.
Immuno AG
Latimer Matthew
LandOfFree
Method for producing influenza virus and vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing influenza virus and vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing influenza virus and vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-205057